Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...
Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...
Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...
6d
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...
A healthcare worker holds weight-loss drug Ozempic. In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback